Boston Scientific's total assets for Q2 2026 were $45.22B, an increase of 1.95% from the previous quarter. MX:BSX total liabilities were $20.04B for the fiscal quarter, a 9.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.